| PERIOD ENDING | 31-Dec-09 | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | | Total Revenue | 548,112 | 488,423 | 441,236 | 389,815 | | Cost of Revenue | 491,816 | 437,005 | 387,753 | 342,280 | | | Gross Profit | 56,296 | 51,418 | 53,483 | 47,535 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 38,167 | 33,731 | 33,505 | 32,417 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 18,129 | 17,687 | 19,978 | 15,118 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 596 | 147 | 365 | 289 | | Earnings Before Interest And Taxes | 18,725 | 17,834 | 20,343 | 15,407 | | Interest Expense | 364 | 366 | 366 | 608 | | Income Before Tax | 18,361 | 17,468 | 19,977 | 14,799 | | Income Tax Expense | 6,546 | 6,533 | 7,473 | 5,570 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 11,815 | 10,935 | 12,504 | 9,229 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 11,815 | 10,935 | 12,504 | 9,229 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $11,815 | $10,935 | $12,504 | $9,229 |
|
1.52% Nasdaq 0.00%
Income Statement
